Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Olivera

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
The Journal of Cell Biology|July 14, 1998
Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survivalJ R Van Brocklyn, M J Lee, R Menzeleev, et al.
Journal of Crohn'S & Colitis|September 10, 2022
Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPablo A Olivera, Juan S Lasa, Ignacio Zubiaurre, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 9, 2005
Early hepatitis C virus changes and sustained response in patients with chronic hepatitis C treated with peginterferon alpha-2b and ribavirinJ F Gallegos-Orozco, A Loaeza-del Castillo, A P Fuentes, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 7, 2024
Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensusPablo A Olivera, Axel Dignass, Marla C Dubinsky, et al.
United European Gastroenterology Journal|May 7, 2021
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseasesFerdinando D'Amico, David T Rubin, Paulo Gustavo Kotze, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|April 3, 2002
School-based hepatitis B immunization program in adolescentsDavid Kershenobich, María Concepción Gutierrez-Ruiz, Marco A Olivera-Martínez, et al.
Journal of Clinical Medicine|October 14, 2023
Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi ConsensusFerdinando D'Amico, Virginia Solitano, Fernando Magro, et al.
World Journal of Hepatology|April 14, 2015
Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3Sebastián Marciano, Silvia M Borzi, Melisa Dirchwolf, et al.
Autoimmunity Reviews|May 11, 2021
Biobetters in patients with immune-mediated inflammatory disorders: An international Delphi consensusFerdinando D'Amico, Virginia Solitano, Daniel Aletaha, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2026
Real-World Outcomes of Upadacitinib Versus Risankizumab Among Anti-TNF Exposed Patients with Crohn's DiseaseCathy McShane, Pablo A Olivera, Kristina Candido, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
The Journal of Cell Biology|July 14, 1998
Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survivalJ R Van Brocklyn, M J Lee, R Menzeleev, et al.
Journal of Crohn'S & Colitis|September 10, 2022
Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPablo A Olivera, Juan S Lasa, Ignacio Zubiaurre, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 9, 2005
Early hepatitis C virus changes and sustained response in patients with chronic hepatitis C treated with peginterferon alpha-2b and ribavirinJ F Gallegos-Orozco, A Loaeza-del Castillo, A P Fuentes, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 7, 2024
Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensusPablo A Olivera, Axel Dignass, Marla C Dubinsky, et al.
United European Gastroenterology Journal|May 7, 2021
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseasesFerdinando D'Amico, David T Rubin, Paulo Gustavo Kotze, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|April 3, 2002
School-based hepatitis B immunization program in adolescentsDavid Kershenobich, María Concepción Gutierrez-Ruiz, Marco A Olivera-Martínez, et al.
Journal of Clinical Medicine|October 14, 2023
Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi ConsensusFerdinando D'Amico, Virginia Solitano, Fernando Magro, et al.
World Journal of Hepatology|April 14, 2015
Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3Sebastián Marciano, Silvia M Borzi, Melisa Dirchwolf, et al.
Autoimmunity Reviews|May 11, 2021
Biobetters in patients with immune-mediated inflammatory disorders: An international Delphi consensusFerdinando D'Amico, Virginia Solitano, Daniel Aletaha, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2026
Real-World Outcomes of Upadacitinib Versus Risankizumab Among Anti-TNF Exposed Patients with Crohn's DiseaseCathy McShane, Pablo A Olivera, Kristina Candido, et al.
Pageof 15